These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 38377635)
1. Lysophosphatidic acid (LPA) receptor-mediated signaling and cellular responses to anticancer drugs and radiation of cancer cells. Ikeda H; Takai M; Tsujiuchi T Adv Biol Regul; 2024 May; 92():101029. PubMed ID: 38377635 [TBL] [Abstract][Full Text] [Related]
2. Roles of lysophosphatidic acid (LPA) receptor-mediated signaling in cancer cell biology. Takai M; Mori S; Honoki K; Tsujiuchi T J Bioenerg Biomembr; 2024 Aug; 56(4):475-482. PubMed ID: 38886303 [TBL] [Abstract][Full Text] [Related]
3. Lysophosphatidic acid receptors in cancer pathobiology. Tsujiuchi T; Araki M; Hirane M; Dong Y; Fukushima N Histol Histopathol; 2014 Mar; 29(3):313-21. PubMed ID: 24194373 [TBL] [Abstract][Full Text] [Related]
4. Diverse effects of LPA receptors on cell motile activities of cancer cells. Tsujiuchi T; Hirane M; Dong Y; Fukushima N J Recept Signal Transduct Res; 2014 Jun; 34(3):149-53. PubMed ID: 24460191 [TBL] [Abstract][Full Text] [Related]
6. Modulation of chemoresistance by lysophosphatidic acid (LPA) signaling through LPA Minami K; Ueda N; Maeda H; Ishimoto K; Otagaki S; Tsujiuchi T Biochem Biophys Res Commun; 2019 Sep; 517(2):359-363. PubMed ID: 31362892 [TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidylethanolamine utilizes LPA(1) and CD97 in MDA-MB-231 breast cancer cells. Park SJ; Lee KP; Kang S; Chung HY; Bae YS; Okajima F; Im DS Cell Signal; 2013 Nov; 25(11):2147-54. PubMed ID: 23838008 [TBL] [Abstract][Full Text] [Related]
9. Regulation of cellular responses to X-ray irradiation through the activation of lysophosphatidic acid (LPA) receptor-3 (LPA Ikeda H; Takai M; Yashiro N; Amano Y; Hara K; Yamamoto M; Tsujiuchi T Pathol Res Pract; 2024 May; 257():155293. PubMed ID: 38615508 [TBL] [Abstract][Full Text] [Related]
11. Role of the autotaxin-lysophosphatidate axis in cancer resistance to chemotherapy and radiotherapy. Brindley DN; Lin FT; Tigyi GJ Biochim Biophys Acta; 2013 Jan; 1831(1):74-85. PubMed ID: 22954454 [TBL] [Abstract][Full Text] [Related]
12. Lysophosphatidic acid (LPA) receptor-mediated signaling regulates hypoxia-induced biological functions of lymphatic endothelial cells. Yamamoto M; Takai M; Yashiro N; Hayasaka H; Tsujiuchi T Biochem Biophys Res Commun; 2024 Jun; 715():149982. PubMed ID: 38676998 [TBL] [Abstract][Full Text] [Related]
13. Positive and Negative Cross-Talk between Lysophosphatidic Acid Receptor 1, Free Fatty Acid Receptor 4, and Epidermal Growth Factor Receptor in Human Prostate Cancer Cells. Hopkins MM; Liu Z; Meier KE J Pharmacol Exp Ther; 2016 Oct; 359(1):124-33. PubMed ID: 27474750 [TBL] [Abstract][Full Text] [Related]
15. LPA receptor1 antagonists as anticancer agents suppress human lung tumours. Zhao PF; Wu S; Li Y; Bao G; Pei JY; Wang YW; Ma Q; Sun HJ; Damirin A Eur J Pharmacol; 2020 Feb; 868():172886. PubMed ID: 31866407 [TBL] [Abstract][Full Text] [Related]
16. Controlling cancer through the autotaxin-lysophosphatidic acid receptor axis. Gotoh M; Fujiwara Y; Yue J; Liu J; Lee S; Fells J; Uchiyama A; Murakami-Murofushi K; Kennel S; Wall J; Patil R; Gupte R; Balazs L; Miller DD; Tigyi GJ Biochem Soc Trans; 2012 Feb; 40(1):31-6. PubMed ID: 22260662 [TBL] [Abstract][Full Text] [Related]
17. Lysophosphatidic acid (LPA) signalling in cell migration and cancer invasion: a focussed review and analysis of LPA receptor gene expression on the basis of more than 1700 cancer microarrays. Willier S; Butt E; Grunewald TG Biol Cell; 2013 Aug; 105(8):317-33. PubMed ID: 23611148 [TBL] [Abstract][Full Text] [Related]
18. Anatomical location of LPA1 activation and LPA phospholipid precursors in rodent and human brain. González de San Román E; Manuel I; Giralt MT; Chun J; Estivill-Torrús G; Rodríguez de Fonseca F; Santín LJ; Ferrer I; Rodríguez-Puertas R J Neurochem; 2015 Aug; 134(3):471-85. PubMed ID: 25857358 [TBL] [Abstract][Full Text] [Related]
19. Regulation of tumor cell - Microenvironment interaction by the autotaxin-lysophosphatidic acid receptor axis. Tigyi GJ; Yue J; Norman DD; Szabo E; Balogh A; Balazs L; Zhao G; Lee SC Adv Biol Regul; 2019 Jan; 71():183-193. PubMed ID: 30243984 [TBL] [Abstract][Full Text] [Related]
20. Structural insights into ligand recognition by the lysophosphatidic acid receptor LPA Taniguchi R; Inoue A; Sayama M; Uwamizu A; Yamashita K; Hirata K; Yoshida M; Tanaka Y; Kato HE; Nakada-Nakura Y; Otani Y; Nishizawa T; Doi T; Ohwada T; Ishitani R; Aoki J; Nureki O Nature; 2017 Aug; 548(7667):356-360. PubMed ID: 28792932 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]